Limited long-term data: most evidence is from animal models, with no long-term human study of NNMT inhibition and oncological endpoints
Only about 20 percent maintain significant weight loss long-term without additional support
Interestingly, although no conclusions can be drawn, the weight loss response to semaglutide 2.4 mg in the BARI-STEP trial appears to be greater than that reported in other semaglutide trials
When prescribed by a healthcare professional and taken as directed, semaglutide can assist in reducing excess sugar circulating in your body and help you reach more stable glucose levels over time
GliSODin helps prevent sun-induced photoaging, boosts skins UV resistance, brightens complexion, and improves microcirculation, collagen, elasticity, and healing